Xiaobao Yang

Title: Innovations in Anti-Tumor Treatments by Inventor Xiaobao Yang

Introduction

Xiaobao Yang is an innovative inventor based in Shanghai, China, who has made significant contributions to the field of anti-tumor treatments. With a total of three patents to his name, Yang's research focuses on novel compounds that target specific proteins associated with tumor growth, showcasing his commitment to advancing medical science and improving cancer therapies.

Latest Patents

Among Xiaobao Yang's latest patents are two remarkable inventions that illustrate his expertise in the development of cutting-edge anti-tumor compounds. The first patent concerns "Target protein degradation compounds, their anti-tumor use, their intermediates and use of intermediates." This invention revolves around a compound composed of three parts: a small molecule compound (SMBP) capable of binding to a target protein, a linker (LIN), and a ubiquitin ligand (ULM). Designed to degrade specific proteins, these compounds hold promise for therapeutic applications in tumor treatments.

The second patent is for an "ALK protein degradation agent and anti-tumor application thereof." This invention features a compound composed of four parts, including ALK-TKI, which has ALK tyrosine kinase inhibitory activity, a variety of linkers, a small molecule ligand for ubiquitination, and a covalently bonded carbonyl group or an absence of it. This series of compounds not only demonstrates degradation and inhibitory effects on ALK target proteins but also showcases their potential in treating related tumors.

Career Highlights

Xiaobao Yang is affiliated with the prestigious ShanghaiTech University, where he actively engages in research and development of innovative medical solutions. His focus on designing pharmacologically active compounds reflects his dedication to improving cancer treatments and providing effective therapeutics for patients grappling with tumorous conditions.

Collaborations

Throughout his career, Xiaobao Yang has had the privilege of collaborating with esteemed colleagues, including Biao Jiang and Jinju Chen. These partnerships enhance his research capabilities and foster an environment of shared knowledge and innovation in the fight against cancer.

Conclusion

In summary, Xiaobao Yang stands out as a visionary inventor in the field of anti-tumor treatments. His latest patents demonstrate a high level of ingenuity and a commitment to advancing therapeutic strategies for cancer. As he continues to explore the potential of novel compounds, Yang's contributions are likely to shape the future of oncological research and therapy.